ABIOMED, Inc.Danvers, MA, United States (NASDAQ (GM): ABMD)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

ABIOMED Financial Statements

ABIOMED Financial Information

Company Type Public
Headquarters
Fiscal Year-End March
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

ABIOMED Income Statement

  2008 2007 2006
Revenue ($ mil.) 58.9 50.7 43.7
Gross Profit ($ mil.) 43.9 38.6 32.0
Operating Income ($ mil.) (36.5) (28.5) (30.3)
Total Net Income ($ mil.) (40.9) (27.9) (29.5)
Diluted EPS (Net Income) (1.26) (1.03) (1.15)
More ABIOMED financial information

ABIOMED Quarterly Statements

  Quarter Ending Mar 08 Quarter Ending Dec 07 Quarter Ending Sep 07
Revenue ($ mil.) 17.5 16.0 11.4
Gross Profit ($ mil.) 12.6 12.3 8.5
Operating Income ($ mil.) (8.9) (8.6) (10.0)
Total Net Income ($ mil.) (15.0) (8.3) (9.4)
Diluted EPS (Net Income) (0.46) (0.25) (0.29)
More ABIOMED financial information

ABIOMED Stock Quote & Chart

09/05/08 14:29:02 EST • NASDAQ • 16.71 • Decreased by -0.1300 • Decreased by -0.7720 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

ABIOMED Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 10.66 2.19 1.56
Price/Earnings Ratio -- 22.29 15.82
Price/Book Ratio 6.71 2.28 1.52
Price/Cash Flow Ratio -- 15.76 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed ABIOMED Financial Ratios

ABIOMED Competitive Intelligence

CardiacAssist Teleflex Thoratec Corp
Annual Sales ($ mil.) 3.2 1,934.3 234.8
Employees 30 14,000 1,164
Market Cap ($ mil.) -- 2,592.5 1,351.6

Competitive Landscape